Search
Although evidence supports clinicians to "safely do less" for febrile infants assessed as low risk of serious bacterial infection (SBI), early discharge may increase caregiver concern and reduce satisfaction with care. We captured the self-reported satisfaction and concerns for families enrolled in the study of fever, blood cultures and readiness for discharge in infants less than 3 months old (FeBRILe3), a prospective safety assessment of early discharge of low-risk febrile infants, to aid evaluation of this practice.
Vancomycin is used to treat serious gram-positive infections in children; however, effective dosing information for those aged 3 months to 18 years is limited. We aimed to determine an optimized dosing strategy for this age group.
As we finalised our analysis of the adoption of mandatory policies for childhood vaccines in four high-income jurisdictions for our publication, “Convergence on Coercion,” every country on earth was grappling with how to drive uptake of COVID-19 vaccines.
Aboriginal health is everyone's business. The needs of Aboriginal and Torres Strait Islander families and kids is integrated into all relevant areas of our work. Improving the health and wellbeing of Aboriginal and Torres Strait Islander kids and families is an overarching priority for every team at The Kids.
We will leverage the unique Western Australian data linkage resources to undertake the definitive twin and sibling study of infection-related hospitalisation
This study investigated host gene expression in response to new HIV infection.
Australian charity celebrates 20 years of providing meningitis awareness and marks World Meningitis Day with footy star
Researchers are an important step closer to finding a vaccine that protects against a wide range of strains of meningococcal B - the most common cause of mening
Perth researcher dedicated to reducing serious chest and ear infections in children has been recognised with the award of Officer in the Order of Australia
Perth researchers are seeking volunteers to test the effectiveness of a vaccine against the debilitating Ross River Virus.